The Adapted POM Analysis of Avenanthramides In Silico

• Main Authors: Tibor Maliar (Author), Mária Maliarová (Author), Andrea Purdešová (Author), Timotej Jankech (Author), Ivana Gerhardtová (Author), Patrik Beňovič (Author), Václav Dvořáček (Author), Michal Jágr (Author), Jana Viskupičová (Author)
• Format: Book
• Published: MDPI AG, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/ph16050717; 1424-8247
• Keywords: avenanthramides; bioactivity; MOLINSPIRATION; OSIRIS; POM analysis; <i>Swiss-ADME</i>; Medicine; R; Pharmacy and materia medica; RS1-441
• Source: Pharmaceuticals, Vol 16, Iss 5, p 717 (2023)

POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule's potential to become a drug candidate. Avenanthramides (AVNs) are promising secondary metabolites specific to <i>Avena</i> spp. (oat). They comprise the amides of anthranilic acid linked to various polyphenolic acids with or without post-condensation molecule transformation. These natural compounds have been reported to exert numerous biological effects, including antioxidant, anti-inflammatory, hepatoprotective, antiatherogenic, and antiproliferative properties. To date, almost 50 various AVNs have been identified. We performed a modified POM analysis of 42 AVNs using MOLINSPIRATION, SWISSADME, and OSIRIS software. The evaluation of primary in silico parameters revealed significant differences among individual AVNs, highlighting the most promising candidates. These preliminary results may help coordinate and initiate other research projects focused on particular AVNs, especially those with predicted bioactivity, low toxicity, optimal ADME parameters, and promising perspectives.